Clinical Trials Browser

Phase 3 × OTHER × tremelimumab × Clear all

NCT04585490 2025-05-06

Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03288532 2020-09-07

RAMPART

Phase 3 Recruiting

Carcinoma, Renal Cell